Gene · 1001
Papers1,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| First CDH3-related HJMD case in a black patient: novel variants and diagnostic odyssey. | Ophthalmic Genet | 2026 | 42675022 | PubTator, text mining | PubMed |
| Multi-Omics Integration Identifies a CDH3-Associated Malignant Epithelial State and Immunosuppressive Niche to Predict Prognosis in Thymic Epithelial Tumors. | Adv Sci (Weinh) | 2026 | 42603286 | PubTator, text mining | PubMed |
| CDH3 Retinopathy: Long-Term Multimodal Follow-Up with Pediatric Multidisciplinary Insights. | J Clin Med | 2026 | 42513307 | PubTator, text mining | PubMed |
| CDH3 in human tumors: tumor biology and potential therapeutic target. | Front Pharmacol | 2026 | 42440815 | PubTator, text mining | PubMed |
| Cadherin-mediated cell adhesion networks drive tumor growth and therapeutic responses in head and neck cancer. | World J Surg Oncol | 2026 | 42421103 | PubTator, text mining | PubMed |
| Cell-cell junction gene signatures as subtype-specific prognostic biomarkers in breast cancer. | PLoS One | 2026 | 42371976 | PubTator, text mining | PubMed |
| Novel Compound Heterozygous Variants in CDH3 Cause Congenital Hypotrichosis with Juvenile Macular Dystrophy: A Case Report with Longitudinal Imaging and Functional Validation. | Case Rep Ophthalmol | 2026 | 42199197 | PubTator, text mining | PubMed |
| AI-Guided De Novo Design of a Caffeine-Induced Protein Dissociation System. | J Am Chem Soc | 2026 | 42184340 | PubTator, text mining | PubMed |
| Oil degradation potential and preliminary genomic insights of Pseudomonas veronii strain KHB2.9 isolated from oil-contaminated coastal soil. | Braz J Biol | 2026 | 42138876 | PubTator, text mining | PubMed |
| CDH3 Mutation in Saudi Arabia: A Case of Hypotrichosis With Juvenile Macular Dystrophy. | Cureus | 2026 | 42109964 | PubTator, text mining | PubMed |
| A pyroptosis-related molecular signature stratifies prognosis and highlights GSDMB-mediated malignancy in intrahepatic cholangiocarcinoma. | Biol Direct | 2026 | 42098854 | PubTator, text mining | PubMed |
| Role of cadherin gene dysregulation in WNT signaling and nasopharyngeal carcinoma. | Cell Div | 2026 | 42050688 | PubTator, text mining | PubMed |
| Identification of novel genomic variants in diabetic nephropathy patients using whole-exome sequencing: a pilot investigation. | Front Endocrinol (Lausanne) | 2026 | 41970998 | PubTator, text mining | PubMed |
| First case report of transformation of adenocarcinoma to adenosquamous carcinoma with giant-cell carcinoma harboring HER2 mutation after zongertinib (BI 1810631) resistance. | Lung Cancer | 2026 | 41962512 | PubTator, text mining | PubMed |
| Targeted proteomic profiling of serum and CSF reveals CASP-8 as a candidate biomarker in anti-NMDAR encephalitis. | J Neuroimmunol | 2026 | 41962323 | PubTator, text mining | PubMed |
| A Novel Anti-Cadherin-19 Monoclonal Antibody (Ca19Mab-8) for Flow Cytometry, Western Blotting, and Immunohistochemistry. | Curr Issues Mol Biol | 2026 | 41899458 | PubTator, text mining | PubMed |
| O-Mannose Glycosylations Influence E-Cadherin Functional Interactions. | Mol Cell Proteomics | 2026 | 41887410 | PubTator, text mining | PubMed |
| Deciphering the coordinated strategy between enzymatic aromatic-ring cleavage and metabolic remodeling for efficient petroleum degradation by Vagococcus fluvialis LH1. | Water Res | 2026 | 41855727 | PubTator, text mining | PubMed |
| Integrative machine learning and molecular docking reveal Narirutin targets ABCC1/ABCG2 for immune microenvironment remodeling in colorectal cancer. | Sci Rep | 2026 | 41741495 | PubTator, text mining | PubMed |
| Connexin 32 constrains a mesenchymal-like switch in differentiated urothelium and luminal cancers. | Life Sci Alliance | 2026 | 41702673 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1001/papers